ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases

NCT00294437 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

376

Enrollment

OTHER

Sponsor class

Stopped underfunding

Conditions

Prostate Cancer

Interventions

DRUG: Zometa

Sponsor

Central European Cooperative Oncology Group